Skip to main content

Table 2 The estimated infarction size between AAβ and NO-AAβ group

From: Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/β-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-up

The peak value of myocardial enzyme Before PS match p value After PS match p value
AAβ (n = 872) NO-AAβ (n = 1833) AAβ (n = 226) NO-AAβ (n = 452)
pMyo (U/L) 69.4 (33–172) 75 (32.8–228) 0.12 75.2 (30.1–184.5) 75.9 (34.8–224.5) 0.32
pCK-MB (ng/mL) 28.3 (6–105) 47.9 (8.8–164) < 0.001 31.9 (8.7–111) 57 (10–164) 0.02
pcTnI (ng/mL) 3.3 (0.64–11.0) 5.1 (1.2–17.1) < 0.001 3.0 (0.72–10.0) 6.0 (1.4–21.1) 0.002
  1. AAβ ACEI/ARB/β-B, Myo myoglobin, CK-MB creatine kinase-myocardial band, cTnI cardiac troponin I, p peak value of
  2. p values for comparisons between the two groups. Significance level was 0.05